Clinical Trial Update: Targeting Treatment-Resistant OUD With Ketamine-Assisted Mindfulness Oriented Recovery Enhancement [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining ketamine-assisted mindfulness-oriented recovery enhancement for treatment-resistant opioid use disorder; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of California, San Diego | Conditions: Opioid Use Disorder | Phase 2 | Status: NOT_YET_RECRUITING